# Petroleum and Chlorinated Solvents in Meconium and the Risk of Hypospadias: A Pilot Study

Florence Rouget, Adele Bihannic, Sylvaine Cordier, Luc Multigner, Marie

Meyer-Monath, Fabien Mercier, Patrick Pladys, Ronan Garlantézec

► To cite this version:

Florence Rouget, Adele Bihannic, Sylvaine Cordier, Luc Multigner, Marie Meyer-Monath, et al. Petroleum and Chlorinated Solvents in Meconium and the Risk of Hypospadias: A Pilot Study. Frontiers in Pediatrics, 2021, 9, 10.3389/fped.2021.640064. hal-03280207

HAL Id: hal-03280207

https://hal.science/hal-03280207v1

Submitted on 7 Jul 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
<figure><img src="image_2.png" /></figure>

# Petroleum and Chlorinated Solvents in Meconium and the Risk of Hypospadias: A Pilot Study

Florence Rouget<fnref n="1" />,²*, Adèle Bihannic², Sylvaine Cordier³, Luc Multigner³, Marie Meyer-Monath⁴, Fabien Mercier⁵, Patrick Pladys⁶ and Ronan Garlantezec<fnref n="1" />

OPEN ACCESS

**Edited by:**
Maria Loane,
Ulster University, United Kingdom

**Reviewed by:**
Philip Joseph Lupo,
Baylor College of Medicine,
United States
Andrea Köhn,
University Hospital
Magdeburg, Germany
A.J. Agopian,
University of Texas Health Science
Center, United States

*Correspondence:
Florence Rouget
florence.rouget@chu-rennes.fr

**Specialty section:**
This article was submitted to
General Pediatrics and Pediatric
Emergency Care,
a section of the journal
Frontiers in Pediatrics

**Received:** 10 December 2020
**Accepted:** 26 April 2021
**Published:** 02 June 2021

**Citation:**
Rouget F, Bihannic A, Cordier S, Multigner L, Meyer-Monath M, Mercier F, Pladys P and Garlantezec R (2021) Petroleum and Chlorinated Solvents in Meconium and the Risk of Hypospadias: A Pilot Study. *Front. Pediatr.* 9:640064. doi: 10.3389/fped.2021.640064

**Background:** Hypospadias is a male congenital malformation that occurs in ~2 of 1,000 births. The association between hypospadias and fetal exposure to environmental chemicals has been studied, but the results are inconsistent. Although several petroleum and chlorinated solvents are suspected to have teratogenic effects, their role in the occurrence of hypospadias has been little studied and never using biomarkers of exposure. We aimed to evaluate the association between fetal exposure to petroleum and chlorinated solvents measured in meconium and the occurrence of hypospadias.

**Methods:** We conducted a pilot case-control study in the maternity of the University Hospital of Rennes (France). Eleven cases of hypospadias and 46 controls were recruited between October 2012 and January 2014. Data from hospital records and maternal self-reported questionnaires, including socio-demographic characteristics and occupational and non-occupational exposure to chemicals, were collected. Meconium samples were collected using a standardized protocol. Levels of petroleum solvents (toluene, benzene, ethylbenzene, and p, m, and o xylene), certain metabolites (mandelic acid, hippuric acid, methylhippuric acid, S-phenylmercapturic acid, S-benzylmercapturic acid, and phenylglyoxylic acid), and two chlorinated solvents (trichloroethylene and tetrachloroethylene) were measured in meconium by gas and liquid chromatography, both coupled to tandem mass spectrometry. Associations between the concentration of each chemical and the occurrence of hypospadias were analyzed using exact logistic regressions adjusted for maternal age, educational level, pre-pregnancy body mass index, and alcohol, and tobacco consumption during pregnancy. Results are presented with odds ratios (ORs) and their 95% confidence intervals (CIs).

**Results:** Quantification rates for petroleum and chlorinated solvents or metabolites ranged from 2.2% (for methylhippuric acid) to 77.1% (for trichloroethylene) of the meconium samples. We found a significant association between the quantification of phenylglyoxylic acid (metabolite of styrene and ethylbenzene) in the meconium and a higher risk of hypospadias (OR = 14.2, 95% CI [2.5–138.7]). The risk of hypospadias was non-significantly elevated for most of the other solvents and metabolites.

<footnote n="1">¹CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)—UMR_S 1085, Rennes, France, ²Brittany Registry of Congenital Anomalies, CHU Rennes, Rennes, France, ³Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)—UMR_S 1085, Rennes, France, ⁴INERIS, Verneuil-en-Halatte, France, ⁵LERES, EHESP, Irset (Institut de recherche en santé, environnement et travail)—UMR_S 1085, Rennes, France, ⁶Univ Rennes, CHU Rennes, Inserm, LTSI-UMR 1099, Rennes, France</footnote>
**Conclusion:** This exploratory study, on a limited number of cases, suggests an association between petroleum solvents and hypospadias. Additional studies are needed to confirm these results and identify the determinants for the presence of these solvents in meconium.

**Keywords:** hypospadias, BTEX, petroleum solvents, chlorinated solvents, meconium, volatile organic compound

## INTRODUCTION

Hypospadias is a male congenital malformation defined by a displaced urethral meatus on the ventral surface of the penis. The prevalence of hypospadias is ~2 in 1,000 total births (male and female) according to EUROCAT and the International Clearinghouse for Birth Defects and Surveillance and Research data (1, 2). However, the geographical variation of its prevalence is large, depending on how it is defined and ascertained, ranging from 0.2 to 3.9 per 1,000 births (2). The etiology remains largely unknown and is likely to be multifactorial, probably involving both genetic and environmental factors (3).

Among the most widespread chemicals, organic solvents are present in a large range of products used at home or at work, including paints, varnishes, inks, and cleaning agents and may be present as volatile organic compounds (VOCs) for some. There are three major organic solvent chemical families: oxygenated, petroleum, and chlorinated solvents. Their main routes of exposure are dermal and respiratory. Although several studies have suggested an association between *in utero* exposure to organic solvents and hypospadias (4–11), only a few have focused on the subtypes (7, 10, 11). The studies of Cordier et al. (10) and Warenbourg et al. (11) suggested an association between the presence of metabolites of urinary glycol ethers, an oxygenated solvent chemical family, during pregnancy and hypospadias. Another study suggested a non-significant elevated risk of hypospadias associated with tetrachloroethylene-contaminated drinking water (estimated using water distribution system modeling software) (7). Certain petroleum solvents, such as “BTEX” (benzene, toluene, ethylbenzene, and *o*,*m*,*p*-xylene), are suspected to act as endocrine disruptors (12) that may affect the hormonal environment during pregnancy and thus the genital development of the fetus. However, they have never been studied in relation to the occurrence of hypospadias in newborns.

Exposure to chlorinated and petroleum solvents could be potentially assessed using biomarkers in urine or serum. However, their relatively short half-lives, especially that of petroleum solvents, limit the assessment of exposure throughout pregnancy, especially during the specific windows of susceptibility. Meconium is a useful matrix to assess fetal exposure (13, 14). It is the first feces to be expelled by the neonate after birth. It is composed of water, lipids, and proteins derived from swallowed amniotic fluid and secretions and desquamated epithelial cells from the fetal intestine (13). It starts being produced from around the 12th to 13th week of gestation, accumulates in the colon, and is passed by the neonate within the first 24–48 h after birth (14). It may therefore reflect cumulative fetal exposure, even to toxicants with a short half-life (parent

molecules or metabolites). Its collection is non-invasive and simple and it provides unequivocal evidence that the chemical has reached the fetus (15). It has already been used to detect fetal exposure to various toxicants, such as illicit drugs (16), alcohol, certain pesticides (17–19), and various non-persistent organic pollutants (20).

The aim of this exploratory study was to evaluate the association between fetal petroleum and chlorinated solvent levels measured in meconium and the risk of hypospadias.

## MATERIALS AND METHODS

### Population

We conducted a pilot case-control study on a subsample of the PENEW (Pregnancy Environment and NEWborn) project, led by the Brittany Registry of Congenital Anomalies, to study the impact of environmental chemical exposure (solvents and pesticides) on congenital malformations in Brittany (France) between October 2012 and December 2018. Cases in the PENEW project consisted of neonates or fetuses affected by any congenital malformation diagnosed at birth in one of the 13 participating maternity wards in Brittany. For each case, the controls were the two following livebirths of the same gender without any birth defects, born in the same maternity and not hospitalized in a neonatal unit. For both cases and controls, exclusion criteria were residence of the mother outside of Brittany and refusal to participate. All cases and controls were ascertained by a pediatrician in charge of the Brittany congenital malformation registry and trained according to EUROCAT classification guidelines (21).

For this study, we selected hypospadias cases and controls that were recruited at birth in the maternity ward of the University Hospital in Rennes during the first 15 months of enrolment (between October 7, 2012 and January 6, 2014).

During the inclusion period, ~5,000 livebirths were recorded in the maternity ward. Cases (N = 11) consisted of male live births diagnosed with hypospadias on the first day of life by a pediatrician. They represented 69% (11/16) of the eligible children born in the maternity during the same period and diagnosed with hypospadias within the first day of life (before expelling the meconium). Hypospadias was defined as an abnormal location of the urethral orifice on the ventral surface of the penis and coded using the International Classification Disease 10 (ICD 10), following EUROCAT guidelines (21). This classification is based on the location of the ectopic meatus, i.e., balanic (Q540), penile (Q541), penoscrotal (Q542), or perineal (Q543). Hypospadias associated with chromosomal and genetic conditions was excluded. All cases were confirmed by
a pediatric surgeon and included in the Brittany registry of congenital anomalies.

Controls (N = 47) consisted of male live birth controls of all PENEW cases (excluding those of syndromic and chromosomic cases) with available meconium analysis (N = 46) and delivered during the same time period. This enabled us to obtain a ratio of one case to four controls to maximize the power of the study.

## Data Collection

During their stay in the maternity ward, the mothers completed a questionnaire after delivery that provided information on their medical history, tobacco exposure during pregnancy (maternal consumption and passive smoking), alcohol consumption, medication during pregnancy, food habits, and occupational and domestic exposure to a large number of environmental pollutants.

Medical data, including obstetrical history, the health of the newborn, and a description of the malformation (for cases), came from hospital medical records, including clinical examination by the pediatrician before discharge and follow-up by pediatric surgeons.

## Indirect Assessment of Exposure to Solvents

We assessed maternal occupational exposure to solvents during pregnancy using two job-exposure matrices (JEMs) constructed by Santé Publique France (French national public health agency), one concerning petroleum solvents (22) and the other concerning chlorinated solvents (23). Each allowed the assessment of exposure to the family of solvents in a single group (petroleum and chlorinated solvents) and to subgroups of solvents within each family: benzene, other aliphatic mineral spirits, motor gasoline, white-spirits, and other light aromatic mixtures, gasoil, fuels, and kerosene for petroleum solvents and chloroform, methylene chloride, tetrachloroethylene, trichloroethylene, and 1,1,1-trichloroethane for chlorinated solvents.

In addition, information about the domestic use of products containing solvents during pregnancy was collected from the questionnaire: frequency of damp cleaning (<5 times/month, between 5 and 20 times/month, more than 20 times/month), home renovation activities (yes/no), and other chemicals used during leisure activities (yes/no) during pregnancy.

## Meconium Collection

Three meconium samples were collected into dedicated stool-culture containers by healthcare staff within the first 2 days of life following a standardized procedure for both cases and controls. Only water and cotton pads were used to clean the diaper area, excluding any use of cream or lotions. The healthcare staff was instructed to use gloves (without talc) instead of hydroalcoholic gel during collection to prevent any contamination of the samples. Samples were immediately frozen and initially stored in a dedicated freezer at -20°C, in the maternity ward, and then transferred to The French National Institute for Industrial Environment and Risk (INERIS) laboratory and stored at -80°C until analysis.

Possible contamination of the diapers by BTEX or chlorinated solvents that could have led to the contamination of the meconium samples was assessed by analyzing the three references of diapers used in the maternity ward during the study period. Details of the chemical analysis, including quality assurance and quality control (QA/QC), are provided in **Supplementary Material 1**. Under these conditions, no BTEX or chlorinated solvents were quantifiable in the three references, except toluene, which was detected at slightly above the limit of quantification for only one.

## Chemical Analysis of Meconium Samples

Meconium samples were analyzed by the INERIS laboratory. A specific analytic method based on headspace (HS) solid phase microextraction (SPME) gas chromatography coupled with mass spectrometry (GC/MS) was developed to detect and quantify aromatic hydrocarbons "BTEX" (benzene, toluene, ethylbenzene, and *o*,*m*,*p*-xylene) and two chlorinated solvents (trichloroethylene and tetrachloroethylene). This method has been described elsewhere (24). The limits of quantification (LOQ) ranged from 0.08 ng/g of meconium (tetrachloroethylene) to 0.12 ng/g (benzene, toluene) (24). Metabolites of BTEX [o-cresol, hippuric acid, mandelic acid (MA), 2-methylhippuric acid (MHA), S-phenylmercapturic acid (s-PMA), and benzylmercapturic acid (s-BMA)], and one metabolite of styrene and ethylbenzene [phenylglyoxylic acid (PGA)] were analyzed by liquid chromatography coupled to tandem mass spectrometry (LC/MS/MS) according to a previously described method (25). The limits of quantification ranged from 4.8 ng/g (MHA) to 174.7 ng/g (o-cresol) (25). Analyses were blindly performed for cases and controls.

## Statistical Analysis

Concentrations of chemicals were classified into quartiles. For association analyses, two categorizations were considered with different cut-offs according to the frequency of quantification among controls. The cut-off was the third quartile if the quantification frequency was above 50% (i.e., for toluene, benzene, and trichloroethylene) or the limit of quantification if the quantification frequency was below 50% (i.e., for other solvents).

Correlations between solvents and metabolites were studied using chi-square or Fisher exact tests, Wilcoxon tests, or Spearman rank correlations, depending on the level of quantification. We explored the relationship between solvent or metabolite concentrations and certain potential sources: tobacco consumption during pregnancy, occupational exposure to chlorinated and petroleum solvents, self-reported domestic uses of products that may contain solvents (for damp cleaning, home renovation, and leisure activities) using chi-square or Fisher exact tests.

We used an exact logistic regression model to study the risk of hypospadias related to BTEX or chlorinated solvents to reduce the small sample bias, which generally leads to overestimation of the true value (26). Associations were tested independently for each chemical and only for those detected in more than 10% of samples. Potential confounders included in
the adjustment set of variables were chosen a priori: maternal age (<25, 25-35, ≥35 years), education level (high school or less, post-secondary school), body-mass index (<25, ≥25 m/kg²), tobacco consumption during pregnancy (yes/no), and alcohol consumption during pregnancy (yes/no). Results are presented as odds ratios (ORs) with their 95% confidence intervals (CIs).

We did not correct *p*-values for multiple testing and accepted the possibility of false discoveries, as our study was a pilot study. Nevertheless, and, as recommended (27, 28), all comparisons were planned a priori and all results are reported.

All statistical analyses were performed using SAS statistical software (version 9.4, SAS Institute Inc., Cary, NC, USA) and LogXact 10 (Cytel).

## RESULTS

The characteristics of the cases and controls are presented in Table 1. Mothers of cases were significantly less educated and more affected by hypertension than those of controls. There were no other significant differences between cases

and controls in terms of other maternal characteristics or environmental exposure.

Among the 11 cases of hypospadias, four were balanic (Q540), five penile (Q541), and two penoscrotal (Q542). Only penoscrotal cases were associated with another malformation (one of esophageal atresia and one of multicystic renal dysplasia).

The frequency of quantification and distribution (in quartiles) of chemical concentrations in the meconium of controls are presented in Table 2. Solvents were quantified from 2.2% of samples for MHA and S-PMA to 63.9% for benzene and 77.1% for trichloroethylene.

There were strong correlations between the levels of several solvents and metabolites (Supplementary Material 2). Such correlations were expected, as these solvents share common major sources of exposure, such as indoor and outdoor air pollution for petroleum solvents.

Among the mothers who declared working during pregnancy, only one was classified as potentially exposed at work to chlorinated solvents (probably to chloroform but not trichloroethylene or tetrachloroethylene) and another was classified as potentially exposed at work to petroleum solvents by

<table><caption>TABLE 1 | Characteristics of the 11 cases of hypospadias and 46 controls.</caption><thead><tr><th rowspan="2"></th><th rowspan="2"></th><th colspan="2">Controls (n = 46)</th><th colspan="2">Cases (n = 11)</th><th rowspan="2">p-value</th></tr><tr><th>n</th><th>%</th><th>n</th><th>%</th></tr></thead><tbody><tr><td rowspan="4">Age</td><td>&lt;25</td><td>3</td><td>6.5</td><td>1</td><td>9.1</td><td rowspan="4">0.91</td></tr><tr><td>25-35</td><td>37</td><td>80.4</td><td>9</td><td>81.8</td></tr><tr><td>≥35</td><td>6</td><td>13.0</td><td>1</td><td>9.1</td></tr><tr><td>mean (± SD)</td><td colspan="2">30.2 (±3.6)</td><td colspan="2">29.3 (± 4.2)</td></tr><tr><td rowspan="2">Educational level</td><td>High school or less</td><td>10</td><td>21.7</td><td>7</td><td>63.6</td><td rowspan="2">0.006</td></tr><tr><td>Postsecondary school</td><td>36</td><td>78.3</td><td>4</td><td>36.7</td></tr><tr><td rowspan="2">Work during pregnancy</td><td>No</td><td>29</td><td>63.0</td><td>6</td><td>55.5</td><td rowspan="2">0.73</td></tr><tr><td>Yes</td><td>17</td><td>37.0</td><td>5</td><td>45.5</td></tr><tr><td rowspan="4">BMI (kg/m²)</td><td>&lt;25</td><td>33</td><td>71.7</td><td>7</td><td>63.6</td><td rowspan="4">0.60</td></tr><tr><td>≥25</td><td>13</td><td>28.3</td><td>4</td><td>36.4</td></tr><tr><td>mean (± SD)</td><td colspan="2">23.5 (± 4.2)</td><td colspan="2">24.3 (± 5.0)</td></tr><tr><td></td><td colspan="2"></td><td colspan="2"></td></tr><tr><td rowspan="2">Tobacco consumption during pregnancy</td><td>No</td><td>31</td><td>67.4</td><td>7</td><td>63.6</td><td rowspan="2">0.81</td></tr><tr><td>Yes</td><td>15</td><td>32.6</td><td>4</td><td>36.4</td></tr><tr><td rowspan="3">Passive smoking during pregnancy</td><td>No</td><td>16</td><td>38.1</td><td>4</td><td>36.4</td><td rowspan="3">0.92</td></tr><tr><td>Yes</td><td>26</td><td>61.9</td><td>7</td><td>63.6</td></tr><tr><td>missing</td><td>4</td><td>-</td><td>0</td><td>-</td></tr><tr><td rowspan="2">Alcohol consumption during pregnancy</td><td>No</td><td>40</td><td>87.0</td><td>11</td><td>100.0</td><td rowspan="2">0.20</td></tr><tr><td>Yes</td><td>6</td><td>13.0</td><td>0</td><td>0.0</td></tr><tr><td rowspan="3">Vitamin Supplementation (beginning pregnancy)</td><td>No</td><td>25</td><td>55.6</td><td>6</td><td>60.0</td><td rowspan="3">0.80</td></tr><tr><td>Yes</td><td>20</td><td>44.4</td><td>4</td><td>40.0</td></tr><tr><td>missing</td><td>1</td><td>-</td><td>1</td><td>-</td></tr><tr><td rowspan="2">Diabetes during pregnancy</td><td>No</td><td>44</td><td>95.7</td><td>10</td><td>90.9</td><td rowspan="2">0.53</td></tr><tr><td>Yes</td><td>2</td><td>4.3</td><td>1</td><td>9.1</td></tr><tr><td rowspan="2">Hypertension (before and during pregnancy)</td><td>No</td><td>46</td><td>100.0</td><td>8</td><td>72.7</td><td rowspan="2">0.003</td></tr><tr><td>Yes</td><td>0</td><td>0.0</td><td>3</td><td>27.3</td></tr><tr><td rowspan="2">SGA 10th percentile (AUDIPOG curves)</td><td>No</td><td>38</td><td>82.6</td><td>8</td><td>72.7</td><td rowspan="2">0.43</td></tr><tr><td>Yes</td><td>8</td><td>17.4</td><td>3</td><td>27.3</td></tr></tbody></table>

BMI, body-mass index; SGA, small for gestational age.
<table><caption>TABLE 2 | Distribution of chemical concentrations in meconium samples (BTEX and chlorinated solvents and metabolites) among controls (n = 46).</caption><thead><tr><th></th><th>N</th><th>LOQ<br>(ng/g)</th><th>N (%)<br>&gt;LOQ</th><th>P25<br>(ng/g)<br>Q1</th><th>P50<br>(ng/g)<br>Q2</th><th>P75<br>(ng/g)<br>Q3</th><th>Maximum<br>(ng/g)</th></tr></thead><tbody><tr><td>Toluene</td><td>35</td><td>0.120</td><td>22 (62.9)</td><td>&lt;LOQ</td><td>3.78</td><td>94.9</td><td>538</td></tr><tr><td>Benzene</td><td>46</td><td>0.120</td><td>33 (63.9)</td><td>&lt;LOQ</td><td>0.300</td><td>1.07</td><td>41.0</td></tr><tr><td>Ethylbenzene</td><td>46</td><td>0.120</td><td>20 (43.5)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>0.540</td><td>3.17</td></tr><tr><td>p-xylene</td><td>46</td><td>0.100</td><td>14 (30.5)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>0.120</td><td>0.920</td></tr><tr><td>m-xylene</td><td>46</td><td>0.120</td><td>15 (32.6)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>0.320</td><td>1.67</td></tr><tr><td>o-xylene</td><td>46</td><td>0.120</td><td>6 (13.0)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>2.54</td></tr><tr><td>Phenylglyoxylic acid (PGA)</td><td>46</td><td>29.9</td><td>3 (6.5)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>403</td></tr><tr><td>O_cresol</td><td>46</td><td>175</td><td>6 (13.0)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>960</td></tr><tr><td>Mandelic acid</td><td>46</td><td>72.2</td><td>5 (9.8)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>122</td></tr><tr><td>Hippuric acid</td><td>46</td><td>17.4</td><td>17 (37.0)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>29.9</td><td>1330</td></tr><tr><td>Methylhippuric acid (MHA)</td><td>46</td><td>4.82</td><td>1 (2.2)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>113</td></tr><tr><td>S-phenylmercapturic acid (S-PMA)</td><td>46</td><td>51.6</td><td>1 (2.2)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>87.3</td></tr><tr><td>S-benzylmercapturic acid (S-BMA)</td><td>46</td><td>10.4</td><td>3 (6.5)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>20.2</td></tr><tr><td>Trichloroethylene</td><td>46</td><td>0.100</td><td>34 (77.1)</td><td>&lt;LOQ</td><td>0.210</td><td>0.350</td><td>0.900</td></tr><tr><td>Tetrachloroethylene</td><td>46</td><td>0.0800</td><td>22 (47.8)</td><td>&lt;LOQ</td><td>&lt;LOQ</td><td>0.230</td><td>0.380</td></tr></tbody></table>

LOQ, limit of quantification.

Q1, 1st quartile; Q2, 2nd quartile; Q3, 3rd quartile.

the JEMs (probably to white spirit but not benzene). Hippuric acid was the only detected metabolite associated with smoking during pregnancy (Supplementary Material 2, Table 1). In terms of self-reported non-occupational exposure, the frequency of damp cleaning was associated with higher quantification rates of ethylbenzene, p-xylene, and o-xylene. Home renovation was associated with higher quantification rates of m-xylene, hippuric acid, and trichloroethylene (Supplementary Material 2, Table 1). Other self-reported exposure to chemicals during leisure-time activities was not associated with any changes in the levels of solvents or their metabolites measured in the meconium samples (Supplementary Material 2, Table 1).

The associations between the levels of chemical exposure and the risk of hypospadias are presented in Table 3. We found a significant association between the levels above the limit of quantification for PGA in meconium samples and a higher risk of hypospadias (OR = 14.2, 95% CI [2.5–138.7]). The risk of hypospadias was elevated for most of the other compounds and metabolites but was not statistically significant.

DISCUSSION

This pilot study shows that several petroleum and chlorinated solvents and their metabolites can be quantified in meconium samples and suggests an association between quantification of PGA in meconium samples and a higher risk of hypospadias. The risk of hypospadias was elevated for most of the other detected solvents and metabolites but was not statistically significant.

This study had several strengths, including the direct assessment of fetal exposure via the analysis of biomarkers in meconium samples, which reflects cumulative exposure starting from the 12th to 13th week of gestation until birth (13, 14, 29). Interestingly, the cumulative exposure traced in this matrix covered the window of susceptibility for the development of

hypospadias: human male urethral development starts from the indifferent stage of genital development at 6–8 weeks gestation, with progression of the urethral meatus from the scrotal folds to its terminal position on the glans, ending at 16–17 weeks (30, 31). The analytical methods were specifically developed and validated for this study (24, 25). Other strengths of our study were the ascertainment and validation of cases by pediatricians and surgeons, which avoided a misclassification bias, and a large number of potential confounders. Although maternal hypertension was associated with hypospadias, we decided a priori to not adjust for it, as it can be considered as an intermediate factor.

This study also had several limitations, mainly due to the small number of cases, leading to imprecision in the estimates (i.e., wide 95% confidence intervals). The low number of cases was due to the necessity of early inclusion after birth, and therefore the early diagnosis of hypospadias, to collect meconium before its being expelled. Certain forms of balanic hypospadias are hidden by an overlapping or tight prepuce and can be difficult to diagnose at birth; the diagnosis is sometimes made later during the stay at the maternity ward by the pediatrician, or even after discharge, by a surgeon. This constraint may have led to the selection of major forms. However, the repartition of anatomical subtypes of hypospadias (balanic, penile, and penoscrotal) was no different between the included and non-included cases born in the same maternity ward during the same period.

This pilot study is the first to focus on “BTEX-Styrene” (BTEX-S) or chlorinated solvent exposure in relation to the occurrence of hypospadias based on measurements in meconium. We found that petroleum solvents could be quantified in 15% to 65% of samples and most of their metabolites in <20%, except for hippuric acid. The levels observed in the present study are difficult to compare, as, to our knowledge, no other study has measured these compounds in meconium. Thus, comparison
<table><caption>**TABLE 3** | Association between the levels of BTEX and chlorinated solvents and their metabolites in the meconium and the occurrence of hypospadias (n = 11 cases and 46 controls).</caption><thead><tr><th></th><th></th><th>Cases<br>(N = 11)</th><th>Controls<br>(N = 46)</th><th>OR [95% CI]</th><th>OR* [95% CI]</th></tr></thead><tbody><tr><td rowspan="2">Toluene#</td><td>&lt;Q3</td><td>5</td><td>26</td><td>Ref</td><td>Ref</td></tr><tr><td>≥Q3</td><td>2</td><td>9</td><td>0.87 [0.11–10.64]</td><td>2.91 [0.12–202.10]</td></tr><tr><td rowspan="2">Benzene</td><td>&lt;Q3</td><td>8</td><td>34</td><td>Ref</td><td>Ref</td></tr><tr><td>≥Q3</td><td>3</td><td>12</td><td>0.94 [0.18–6.41]</td><td>2.67 [0.28–34.34]</td></tr><tr><td rowspan="2">Ethylbenzene</td><td>&lt;LOQ</td><td>4</td><td>26</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>7</td><td>20</td><td>2.27 [0.58–8.86]</td><td>1.81 [0.46–7.61]</td></tr><tr><td rowspan="2">p-Xylene</td><td>&lt;LOQ</td><td>6</td><td>32</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>5</td><td>14</td><td>1.90 [0.50–7.29]</td><td>2.38 [0.53–11.17]</td></tr><tr><td rowspan="2">m-Xylene</td><td>&lt;LOQ</td><td>4</td><td>31</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>7</td><td>15</td><td>3.61 [0.92–14.30]</td><td>3.17 [0.76–14.00]</td></tr><tr><td rowspan="2">o-Xylene</td><td>&lt;LOQ</td><td>8</td><td>40</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>3</td><td>6</td><td>2.50 [0.51–12.39]</td><td>2.77 [0.43–17.55]</td></tr><tr><td rowspan="2">Phenylglyoxylic acid (PGA)</td><td>&lt;LOQ</td><td>6</td><td>43</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>5</td><td>3</td><td>11.94 [2.25–63.25]</td><td>14.17 [2.45–138.66]</td></tr><tr><td rowspan="2">o-Cresol</td><td>&lt;LOQ</td><td>9</td><td>40</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>2</td><td>6</td><td>1.48 [0.26–8.58]</td><td>2.12 [0.31–12.48]</td></tr><tr><td rowspan="2">Mandelic acid</td><td>&lt;LOQ</td><td>11</td><td>41</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>0</td><td>5</td><td>–</td><td>–</td></tr><tr><td rowspan="2">Hippuric Acid</td><td>&lt;LOQ</td><td>7</td><td>29</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>4</td><td>17</td><td>0.97 [0.24–3.82]</td><td>2.25 [0.42–14.57]</td></tr><tr><td rowspan="2">Methylhippuric acid (MHA)</td><td>&lt;LOQ</td><td>11</td><td>45</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>0</td><td>1</td><td>–</td><td>–</td></tr><tr><td rowspan="2">S-phenylmercapturic acid (S-PMA)</td><td>&lt;LOQ</td><td>11</td><td>45</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>0</td><td>1</td><td>–</td><td>–</td></tr><tr><td rowspan="2">S-benzylmercapturic acid (S-BMA)</td><td>&lt;LOQ</td><td>10</td><td>43</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>1</td><td>3</td><td>0.70 [0.05–40.25]</td><td>0.62 [0.03–12.56]</td></tr><tr><td rowspan="2">Trichloroethylene</td><td>&lt;Q3</td><td>7</td><td>34</td><td>Ref</td><td>Ref</td></tr><tr><td>≥Q3</td><td>4</td><td>12</td><td>0.62 [0.13–3.43]</td><td>1.41 [0.22–8.04]</td></tr><tr><td rowspan="2">Tetrachloroethylene</td><td>&lt;LOQ</td><td>6</td><td>24</td><td>Ref</td><td>Ref</td></tr><tr><td>≥LOQ</td><td>5</td><td>22</td><td>0.91 [0.24–3.40]</td><td>1.25 [0.32–5.04]</td></tr></tbody></table>

with other biomonitoring studies using other matrices are difficult to interpret, even if BTEX-S have been widely detected in the general population in blood samples (32) and their metabolites in blood and urine samples (33–35). For example, NHANES biomonitoring studies of urine among children in 2005–2012 (35) detected PGA in more than 90% of samples, suggesting that exposure to PGA is indeed widespread compared to the 6.5% of quantification in our study. However, little is known about the fetal pharmacokinetics and metabolism of PGA and we cannot currently infer external exposure associated with the potential increased risk suggested by our results. In non-occupational settings, the major source of exposure to BTEX-S comes from exposure to tobacco (35, 36), as well as indoor and outdoor air pollution (37–39). In addition, BTEX-S have been reported to be present in food (40, 41), although this source of exposure contributed less than other sources, except

for styrene, for which food appeared to contribute to the same extent as airborne exposure (42). In our study, the levels of BTEX, their metabolites, and chlorinated solvents were not associated with occupational exposure or to tobacco (maternal consumption or passive exposure), except for hippuric acid (for maternal consumption only). The relationship between the presence of BTEX or their metabolites in the meconium and airborne or food sources could not be investigated in our study. However, the domestic use of solvents through cleaning habits (damp cleaning) or renovation activities was associated with more frequent detection of ethylbenzene, p-xylene, and o-xylene (damp cleaning), and m-xylene, hippuric acid, and trichloroethylene (home renovation). Home renovation has already been found to be associated with BTEX-S levels in a study on predictors of indoor BTEX concentrations in Canadian homes (43). Finally, although the French Agency for Food,

<footnote>#Toluene measurements were available for seven cases and 35 controls.</footnote>

<footnote>OR, Odds ratio; 95% CI, 95% confidence interval.</footnote>

<footnote>*Adjusted for maternal age, educational level, body-mass index, and alcohol and tobacco consumption during pregnancy.</footnote>

<footnote>LOQ, limit of quantification (LOQ = 0.12 mg/g for ethylbenzene, m-xylene, o-xylene; 0.10 mg/g for p-xylene; 29.92 mg/g for PGA; 174.69 mg/g for O-cresol; 17.36 mg/g for hippuric acid; and 0.08 mg/g for tetrachloroethylene).</footnote>

<footnote>Q3, third quartile (Q3 = 91.9 ng/g for toluene, 1.07 ng/g for benzene, and 0.35 ng/g for trichloroethylene).</footnote>
Environmental and Occupational Health and Safety (ANSES) has reported that several brands of diapers contain BTEX-S, such as o-, m-, and p-xylene, toluene, and styrene (44), the analyses we conducted on the diapers used in our maternity ward before the study did not show any contamination by BTEX-S. We consequently did not consider the diapers themselves to be a possible source of these compounds. PGA, the only metabolite significantly associated with a higher risk of hypospadias in our study, has no known sources other than the metabolization of styrene and ethylbenzene (45).

Our study is the first to focus on the potential association of maternal exposure to BTEX and chlorinated solvents and the risk of hypospadias using objective measures for fetal assessment. Animal data have suggested that BTEX (46–48), styrene (49, 50), and chlorinated solvents (51, 52) can be teratogens. However, their association with male genital malformations has been rarely investigated. Although Bolden et al. suggested that BTEX-S may have endocrine disrupting properties at exposure levels below reference concentrations, the evidence is scarce (12, 52, 53). However, an experimental study in rats showed that styrene, one of the principal sources of PGA, has estrogenic properties that can affect genital development of the offspring, such as shortened anogenital distance, lower testis weight, and disruption of hormonal levels (41). In addition, ethylbenzene, the other precursor of PGA, was found to be associated with urinary tract malformations in the mouse in one study, but this was not observed in other developmental studies (54).

Our pilot study reports the feasibility of measuring petroleum solvents and chlorinated solvents and their metabolites in the meconium and suggests an association between petroleum solvents, especially PGA, and the occurrence of hypospadias. Although such an association is biologically plausible, we recognize that it may be due to a marker of co-exposure not investigated in our study, residual confounding or simply a chance finding. Given the small sample size, these results must be interpreted with caution and additional studies are needed to replicate them. If confirmed, these results may be of particular importance for the prevention of hypospadias.

## DATA AVAILABILITY STATEMENT

The datasets presented in this article are not readily available because of regulatory restrictions. Requests to access the datasets should be directed to Violaine Benoit, violaine.benoit@chu-rennes.fr.

## REFERENCES

1. Bergman JEH, Loane M, Vrijheid M, Pierini A, Nijman RJM, Addor M-C, et al. Epidemiology of hypospadias in Europe: a registry-based study. *World J Urol.* (2015) 33:2159–67. doi: 10.1007/s00345-015-1 507-6

2. Yu X, Nassar N, Mastroiacovo P, Canfield M, Groisman B, Bermejo- Sánchez E, et al. Hypospadias prevalence and trends in international birth defect surveillance systems, 1980-2010. *Eur Urol.* (2019) 76:482–90. doi: 10.1016/j.eururo.2019.06.027

## ETHICS STATEMENT

The studies involving human participants were reviewed and approved by all required ethics committee in France: Person Protection Committee (Comité de Protection des Personnes Ouest V): reference 11/22-811 (06/09/2011); ANSM (AFSSAPS): ID-RCB: 2010-A01445-34-Ref. AFSSAPS: B110827-40- Authorization 01/07/2011; CCTIRS: n° 11.590—Approval on 20/11/2011; CNIL: n° 911526—Approval DR-2012-332 on 03/07/2012. Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin and the mothers.

## AUTHOR CONTRIBUTIONS

FR, SC, PP, LM, and RG contributed conception and design of the study. FR contributed to acquisition and interpretation of data. AB organized the database and contributed to the statistical analyses. MM-M performed the chemical analysis. RG performed the statistical analysis. FR and RG wrote the first draft of the manuscript. FR, RG, and FM wrote sections of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.

## FUNDING

This research was part of the PENEW study, which was funded by the French National Clinical Research Hospital Program (2010).

## ACKNOWLEDGMENTS

We thank all the maternity staff (nurses, assistant nurses, midwives, pediatricians, and obstetricians) for their active participation in the inclusions of the cases and controls and collection of the meconium samples. We thank the staff of the Center of Biological Resources of the CHU of Rennes for storing the meconium samples. The authors thank Gaëlle Saramito at LERES for her contribution to the analysis of the diapers.

## SUPPLEMENTARY MATERIAL

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fped. 2021.640064/full#supplementary-material

3. van der Zanden LF, van Rooij IA, Feitz WF, Franke B, Knoers NV, Roeleveld N. Aetiology of hypospadias: a systematic review of genes and environment. *Hum Reprod Update.* (2012) 18:260–83. doi: 10.1093/humupp/dms002

4. Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. *Birt Defects Res A Clin Mol Teratol.* (2010) 88:910–9. doi: 10.1002/bdra.20707

5. Kalfa N, Paris F, Philibert P, Orsini M, Broussous S, Fauconnet-Servant N, et al. Is hypospadias associated with prenatal exposure to endocrine disruptors? A French Collaborative Controlled Study of a Cohort of 300
Consecutive Children Without Genetic Defect. *Eur Urol.* (2015) 68:1023-30.
doi: 10.1016/j.eurouo.2015.05.008

6. Garlantézec R, Monfort C, Rouget F, Cordier S. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population. *Occup Environ Med.* (2009) 66:456-63.
doi: 10.1136/oem.2008.041772

7. Aschengrau A, Gallagher LG, Winter M, Butler L, Patricia Fabian M, Vieira VM. Modeled exposure to tetrachloroethylene-contaminated drinking water and the occurrence of birth defects: a case-control study from Massachusetts and Rhode Island. *Environ Health.* (2018) 17:75.
doi: 10.1186/s12940-018-0419-5

8. Spinder N, Prins JR, Bergman JEH, Smidt N, Kromhout H, Boezen HM, et al. Congenital anomalies in the offspring of occupationally exposed mothers: a systematic review and meta-analysis of studies using expert assessment for occupational exposures. *Hum Reprod.* (2019) 34:903-19.
doi: 10.1093/humrep/dez033

9. Haraux E, Braun K, Buisson P, Stéphan-Blanchard E, Devauchelle C, Ricard J, et al. Maternal exposure to domestic hair cosmetics and occupational endocrine disruptors is associated with a higher risk of hypospadias in the offspring. *Int J Environ Res Public Health.* 29. (2016) 14:27.
doi: 10.3390/ijerph14010027

10. Cordier S, Garlantézec R, Labat L, Rouget F, Monfort C, Bonvallot N, et al. Exposure during pregnancy to glycol ethers and chlorinated solvents and the risk of congenital malformations. *Epidemiol Camb Mass.* (2012) 23:806-12.
doi: 10.1097/EDE.0b013e31826c2bd8

11. Warembourg C, Botton J, Lelong N, Rouget F, Khoshnood B, Le Gléau F, et al. Prenatal exposure to glycol ethers and cryptorchidism and hypospadias: a nested case-control study. *Occup Environ Med.* (2018) 75:59-65.
doi: 10.1136/oemed-2017-104391

12. Bolden AL, Kwiatkowski CF, Colborn T. New look at BTEX: are ambient levels a problem? *Environ Sci Technol.* (2015) 49:5261-76. doi: 10.1021/es505316f

13. Bearer CF. Meconium as a biological marker of prenatal exposure. *Ambul Pediatr Off J Ambul Pediatr Assoc.* (2003) 3:40-3. doi: 10.1367/1539-4409
(2003) 003<0040:MAABMO>2.0.CO;2

14. Lisowska-Myjak B, Skarzyńska E, Wojdan K, Nasierowska-Guttmejer A. Protein and peptide profiles in neonatal meconium. *J Obstet Gynaecol Res.* (2019) 45:556-64. doi: 10.1111/jog.13888

15. Arbuckle TE. Maternal-infant biomonitoring of environmental chemicals: the epidemiologic challenges. *Birt Defects Res A Clin Mol Teratol.* (2010) 88:931-7.
doi: 10.1002/bdra.20694

16. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. *J Chromatogr B Biomed Sci App.* (1998) 713:137-46.
doi: 10.1016/S0378-4347(97)00479-9

17. Ostrea EM, Bielawski DM, Posecion NC, Corrion M, Villanueva-Uy E, Bernardo RC, et al. Combined analysis of prenatal (maternal hair and blood) and neonatal (infant hair, cord blood and meconium) matrices to detect fetal exposure to environmental pesticides. *Environ Res.* (2009) 109:116-22.
doi: 10.1016/j.envres.2008.09.004

18. Berton T, Mayhoub F, Chardon K, Duca R-C, Lestremau F, Bach V, et al. Development of an analytical strategy based on LC-MS/MS for the measurement of different classes of pesticides and theirs metabolites in meconium: application and characterisation of foetal exposure in France. *Environ Res.* (2014) 132:311-20. doi: 10.1016/j.envres.2014.03.034

19. Haraux E, Tourneux P, Kouakam C, Stephan-Blanchard E, Boudailliez B, Leke A, et al. Isolated hypospadias: the impact of prenatal exposure to pesticides, as determined by meconium analysis. *Environ Int.* (2018) 119:20-5.
doi: 10.1016/j.envint.2018.06.002

20. Li L-X, Chen L, Meng X-Z, Chen B-H, Chen S-Q, Zhao Y, et al. Exposure levels of environmental endocrine disruptors in mother-newborn pairs in China and their placental transfer characteristics. *PLoS One.* (2013) 8:e62526.
doi: 10.1371/journal.pone.0062526

21. **EUROCAT-JRC.** EUROCAT Guide 1.4: Instruction for the Registration of Congenital Anomalies. (2020). Available online at: https://eu-rd-platform.jrc.ec.europa.eu/sites/default/files/JRC-EUROCAT-Full-Guide-1.4-version-23-Sep-2020.pdf (accessed November 12, 2020).

22. Pilorgen C, Dananché B, Luce D, Févotte J, the Matégé working group. Éléments Techniques Sur L'exposition Professionnelle Aux Carburants et Solvants Pétroliers. Matrice Emplois-Expositions Aux Carburants et

Solvants Pétroliers. Saint-Maurice: InVS Umrestte Lyon (2007). Available online at : https://expros.santepubliquefrance.fr/matrices;jsessionid=87854BCC5F1BF896A31381DDCA6D841F (accessed November 12, 2020).

23. Dananché B, Févotte J, the Matégé working group. Éléments Techniques Sur l'exposition Professionnelle à Cinq Solvants Chlorés (Trichloroéthylène, Perchloroéthylène, Chlorure de Méthyleène, Tétrachlorure de Carbone, Chloroforme) - Matrices Emploisexpositions à Cinq Solvants Chlorés. Saint-Maurice (Fra): Institut de veille sanitaire - Umrestte Lyon (2009). 29 p. Available online at : https://expros.santepubliquefrance.fr/matrices;jsessionid=87854BCC5F1BF896A31381DDCA6D841F (accessed November 12, 2020).

24. Meyer-Monath M, Beaumont J, Morel I, Rouget F, Tack K, Lestremau F. Analysis of BTEX and chlorinated solvents in meconium by headspace-solid-phase microextraction gas chromatography coupled with mass spectrometry. *Anal Bioanal Chem.* (2014) 406:4481-90. doi: 10.1007/s00216-014-7836-2

25. Meyer-Monath M, Chatellier C, Rouget F, Morel I, Lestremau F. Development of a multi-residue method in a fetal matrix: analysis of meconium. *Anal Bioanal Chem.* (2014) 406:7785-97. doi: 10.1007/s00216-014-8243-4

26. Maiti T, Pradhan V. A comparative study of the bias corrected estimates in logistic regression. *Stat Methods Med Res.* (2008) 17:621-34.
doi: 10.1177/0962280207084156

27. Rothman KJ, Greenland S, Las TL. Modern Epidemiology, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins (2008).

28. Bender R, Lange S. Adjusting for multiple testing–when and how? *J Clin Epidemiol.* (2001) 54:343-9. doi: 10.1016/S0895-4356(00)00314-0

29. Barr DB, Wang RY, Needham LL. Biologic monitoring of exposure to environmental chemicals throughout the life stages: requirements and issues for consideration for the National Children's Study. *Environ Health Perspect.* (2005) 113:1083-91. doi: 10.1289/ehp.7617

30. Baskin L, Cao M, Sinclair A, Li Y, Overland M, Isaacson D, et al. Androgen and estrogen receptor expression in the developing human penis and clitoris. *Differ Res Biol Divers.* (2020) 111:41-59. doi: 10.1016/j.diff.2019.08.005

31. Li Y, Sinclair A, Cao M, Shen J, Choudhry S, Botta S, et al. Canalization of the urethral plate precedes fusion of the urethral folds during male penile urethral development: the double zipper hypothesis. *J Urol.* (2015) 193:1353-60. doi: 10.1016/j.juro.2014.09.108

32. Chambers DM, Ocariz JM, McGuirk MF, Blount BC. Impact of cigarette smoking on volatile organic compound (VOC) blood levels in the U.S. population: NHANES 2003-2004. *Environ Int.* (2011) 37:1321-8.
doi: 10.1016/j.envint.2011.05.016

33. Fustinoni S, Rossella F, Campo L, Mercadante R, Bertazzi PA. Urinary BTEX, MTBE and naphthalene as biomarkers to gain environmental exposure profiles of the general population. *Sci Total Environ.* (2010) 408:2840-9.
doi: 10.1016/j.scitotenv.2010.03.017

34. Protano C, Andreoli R, Manini P, Vitali M. Urinary trans, trans-muconic acid and S-phenylmercapturic acid are indicative of exposure to urban benzene pollution during childhood. *Sci Total Environ.* (2012) 435-436:115-23. doi: 10.1016/j.scitotenv.2012.07.004

35. Capella KM. Ethylbenzene and styrene exposure in the United States based on urinary mandelic acid and phenylglyoxylic acid_NHANES 2005-2006 and 2011-2012. *Environ Res.* (2019) 171:101-10. doi: 10.1016/j.envres.2019.01.018

36. Skender L, Brcić I, Karacić V. Urine analysis for the evaluation of environmental exposures to aromatic hydrocarbons. *Arch Environ Health.* (2004) 59:237-44. doi: 10.3200/AEOH.59.5.237-244

37. Mohamed MF, Kang D, Aneja VP. Volatile organic compounds in some urban locations in United States. *Chemosphere.* (2002) 47:863-82.
doi: 10.1016/S0045-6535(02)00107-8

38. Barros N, Carvalho M, Silva C, Fontes T, Prata JC, Sousa A, et al. Environmental and biological monitoring of benzene, toluene, ethylbenzene and xylene (BTEX) exposure in residents living near gas stations. *J Toxicol Environ Health A.* (2019) 82:550-63. doi: 10.1080/15287394.2019.1634380

39. Symanski E, Stock TH, Tee PG, Chan W. Demographic, residential, and behavioral determinants of elevated exposures to benzene, toluene, ethylbenzene, and xylenes among the U.S. population: results from 1999-2000 NHANES. *J Toxicol Environ Health A.* (2009) 72:915-24.
doi: 10.1080/15287390902959706
40. Cao X-L, Sparling M, Dabeka R. Occurrence of 13 volatile organic compounds in foods from the Canadian total diet study. *Food Addit Contam Part Chem Anal Control Expo Risk Assess.* (2016) 33:373-82. doi: 10.1080/19440049.2015.1129072

41. Ohyama K-I, Satoh K, Sakamoto Y, Ogata A, Nagai F. Effects of prenatal exposure to styrene trimers on genital organs and hormones in male rats. *Exp Biol Med Maywood NJ.* (2007) 232:301-8. doi: 10.3181/00379727-207-2320301

42. Cao X-L, Sparling M, Pelletier L, Dabeka R. Styrene in foods and dietary exposure estimates. *Food Addit Contam Part Chem Anal Control Expo Risk Assess.* (2018) 35:2045-51. doi: 10.1080/19440049.2018.1512760

43. Wheeler AJ, Wong SL, Khoury C, Zhu J. Predictors of indoor BTEX concentrations in Canadian residences. *Health Rep.* (2013) 24:9.

44. ANSES. *Sécurité des Couches Pour Bébé*. Rapport D'expertise Collective (2019). Available online at: https://www actu-environnement com/media/pdf/news-32742-avis-anses.pdf (accessed November 12, 2020).

45. National Center for Biotechnology Information. PubChem Compound Summary for CID 11915, Benzoylformic Acid. Available online at: https://pubchem.ncbi.nlm.nih.gov/compound/Benzoylformic-acid (accessed November 12, 2020).

46. Mirkova E, Zaikov C, Antov G, Mikhailova A, Khinkova L, Benchev I. Prenatal toxicity of xylene. *J Hyg Epidemiol Microbiol Immunol.* (1983) 27:337-43.

47. Marks TA, Ledoux TA, Moore JA. Teratogenicity of a commercial xylene mixture in the mouse. *J Toxicol Environ Health.* (1982) 9:97-105. doi: 10.1080/15287398209530145

48. Saillenfait AM, Gallissot F, Morel G, Bonnet P. Developmental toxicities of ethylbenzene, ortho-, meta-, para-xylene and technical xylene in rats following inhalation exposure. *Food Chem Toxicol.* (2003) 41:415-29. doi: 10.1016/S0278-6915(02)00231-4

49. Vainio H, Hemminki K, Elovaara E. Toxicity of styrene and styrene oxide on chick embryos. *Toxicology.* (1977) 8:319-25. doi: 10.1016/0300-483X(77)90079-8

50. Sikov MR, Cannon WC, Carr DB, Miller RA, Niemeier RW, Hardin BD. Reproductive toxicology of inhaled styrene oxide in rats and rabbits. *J Appl Toxicol JAT.* (1986) 6:155-64. doi: 10.1002/jat.25500 60304

51. Urban JD, Wikoff DS, Chappell GA, Harris C, Haws LC. Systematic evaluation of mechanistic data in assessing *in utero* exposures to trichloroethylene and development of congenital heart defects. *Toxicology.* (2020) 436:152427. doi: 10.1016/j.tox.2020.152427

52. Hardin BD, Kelman BJ, Brent RL. Trichloroethylene and dichloroethylene: a critical review of teratogenicity. *Birt Defects Res A Clin Mol Teratol.* (2005) 73:931-55. doi: 10.1002/bdra. 20192

53. Bolden AL, Schultz K, Pelch KE, Kwiatkowski CF. Exploring the endocrine activity of air pollutants associated with unconventional oil and gas extraction. *Environ Health.* (2018) 17:26. doi: 10.1186/s12940-018- 0368-z

54. The Agency for Toxic Substances and Disease Registry (ATSDR). *Toxicological Profile for Ethylbenzene*. (2010). Available online at: http://www.atsdr.cdc.gov/toxprofiles (accessed November 12, 2020).

**Conflict of Interest:** The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Rouget, Bihannic, Cordier, Multigner, Meyer-Monath, Mercier, Pladys and Garlantezec. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.